Bio-Rad Laboratories Cash on Hand 2010-2022 | BIO.B

Bio-Rad Laboratories cash on hand from 2010 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Bio-Rad Laboratories cash on hand for the quarter ending March 31, 2022 was $2.079B, a 102.75% increase year-over-year.
  • Bio-Rad Laboratories cash on hand for 2021 was $0.875B, a 12.16% decline from 2020.
  • Bio-Rad Laboratories cash on hand for 2020 was $0.997B, a 11.03% decline from 2019.
  • Bio-Rad Laboratories cash on hand for 2019 was $1.12B, a 31.73% increase from 2018.
Bio-Rad Laboratories Annual Cash on Hand
(Millions of US $)
2021 $875
2020 $997
2019 $1,120
2018 $850
2017 $761
2016 $844
2015 $790
2014 $698
2013 $609
2012 $921
2011 $813
2010 $1,032
2009 $745
Bio-Rad Laboratories Quarterly Cash on Hand
(Millions of US $)
2022-03-31 $2,079
2021-12-31 $875
2021-09-30 $1,343
2021-06-30 $1,167
2021-03-31 $1,025
2020-12-31 $997
2020-09-30 $1,160
2020-06-30 $1,037
2020-03-31 $1,042
2019-12-31 $1,120
2019-09-30 $985
2019-06-30 $987
2019-03-31 $865
2018-12-31 $850
2018-09-30 $866
2018-06-30 $824
2018-03-31 $768
2017-12-31 $761
2017-09-30 $721
2017-06-30 $717
2017-03-31 $679
2016-12-31 $844
2016-09-30 $810
2016-06-30 $796
2016-03-31 $753
2015-12-31 $790
2015-09-30 $786
2015-06-30 $728
2015-03-31 $711
2014-12-31 $698
2014-09-30 $703
2014-06-30 $648
2014-03-31 $641
2013-12-31 $609
2013-09-30 $562
2013-06-30 $834
2013-03-31 $837
2012-12-31 $921
2012-09-30 $854
2012-06-30 $835
2012-03-31 $807
2011-12-31 $813
2011-09-30 $910
2011-06-30 $886
2011-03-31 $798
2010-12-31 $1,032
2010-09-30 $738
2010-06-30 $718
2010-03-31 $692
2009-12-31 $745
2009-09-30 $642
2009-06-30 $563
2009-03-31 $223
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.907B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00